Drugs / Soluble beta-1,3/1,6-glucan
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00283426 | Jan 2006 → Mar 2007 | — | Biotec Pharmacon ASA | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Soluble beta-1,3/1,6-glucan | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00283426 ↗ |